Created in 2010 (Denmark), CIPRALEX OROTAB own 169 sister brands and 4958 competing brands. CIPRALEX OROTAB is owned by H. Lundbeck, listed on the stock exchange of Etats-Unis The International Securities Identification Number (ISIN) of H. Lundbeck is DK0010287234. CIPRALEX OROTAB is part of the Drug Manufacturers activity sector.

CIPRALEX OROTAB is a brand of H. Lundbeck (HLUKF) Sustainability

International deposit : 2010 Business sector Drug Manufacturers
Here is the evolution of interest in H. Lundbeck "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "CIPRALEX OROTAB sustainability"
Sustainability -> Share price